Suppr超能文献

泰国的 Vogt-Koyanagi-Harada 病。

Vogt-Koyanagi-Harada disease in Thailand.

机构信息

Department of Ophthalmology, Chiang Mai University, Chiang Mai, Thailand.

出版信息

Ocul Immunol Inflamm. 2012 Dec;20(6):419-22. doi: 10.3109/09273948.2012.723780. Epub 2012 Nov 19.

Abstract

PURPOSE

To determine clinical characteristics and rate of ocular complications in patients with Vogt-Koyanagi-Harada disease (VKH).

METHODS

The authors performed a retrospective review of 48 consecutive patients (92 affected eyes) diagnosed with VKH. Demographic data, clinical manifestations, treatment modalities, and ocular complications were registered.

RESULTS

VKH constituted approximately 10% of all new encounters of uveitis patients. Ocular complications developed in 49/92 (53%) eyes. The most frequent complication was cataract (45%), followed by glaucoma (29%). The presence of ocular complications was not associated with stage of the disease at presentation (p = .654) or the treatment modalities (p = .261). Recurrent inflammation developed in 13% and was not associated with initial intravenous corticosteroids or use of immunosuppressive drugs (p = .614 and p = 1.000).

CONCLUSIONS

Cataract and glaucoma represented the common ocular complications of VKH. Recurrences developed solely in 13% of patients and were not associated with a specific treatment regimen but with an early withdrawal of systemic corticosteroids.

摘要

目的

确定 Vogt-小柳-原田病(VKH)患者的临床特征和眼部并发症发生率。

方法

作者对 48 例(92 只受累眼)确诊为 VKH 的连续患者进行了回顾性研究。登记了人口统计学数据、临床表现、治疗方式和眼部并发症。

结果

VKH 约占所有葡萄膜炎新发病例的 10%。49/92(53%)只眼出现眼部并发症。最常见的并发症是白内障(45%),其次是青光眼(29%)。眼部并发症的发生与疾病的分期(p=0.654)或治疗方式(p=0.261)无关。13%的患者出现复发性炎症,与初始静脉用皮质类固醇或免疫抑制药物的使用无关(p=0.614 和 p=1.000)。

结论

白内障和青光眼是 VKH 的常见眼部并发症。仅 13%的患者出现复发,与特定的治疗方案无关,而与全身皮质类固醇的早期停药有关。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验